Dr Jacinth Fairley has been the chief executive of Starpharma Holdings since 2006.
Dr Fairley has more than 30 years of operational experience in the pharmaceutical and biotechnology industries, working in business development and senior management roles in companies including CSL and Faulding/Hospira (now part of Pfizer).
Dr Fairley is also chair of the Invest Victoria Advisory Board, a board member of the Melbourne Business School, and an advisor to the Carnegie Innovation Fund.